Literature DB >> 31131950

Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China.

Haona Li1,2, Jianxiong Deng3, Lewen Deng3, Xuequn Ren2, Jielai Xia1.   

Abstract

PURPOSE: Although a series of serious adverse events have continually raised concerns about the potential toxicity of traditional Chinese medicine injections (TCM injections), studies on this subject are still sparse. We conducted a descriptive analysis of a spontaneous reporting system in China to describe the safety profile of TCM injections.
METHODS: The safety profile of TCM injections is described by descriptive analysis of 559 066 adverse reports collected from Guangdong Provincial Center for adverse drug reaction (ADR) Monitoring in China during 2003 to 2017.
RESULTS: The percentage of new or serious ADRs of TCM injections is much higher than average percentage of China's spontaneous reporting system (SRS) as a whole (48.70% vs <25%). Compared with conventional injections, TCM injections have a slightly lower percentage of serious ADRs (6.02% vs 6.72%) and much higher percentage of unknown (new) ADRs (46.74% vs 24.13%). The gender and age distribution for TCM injections are similar to conventional injections. The reporting rates of ADRs increased with age. Anaphylactic shock and anaphylactoid reaction are high-risk ADRs for TCM injections and, anaphylactic shock is ranked number 1 in causing deaths (50.00%).
CONCLUSIONS: There are some differences and similarities on the safety profile between TCM injections and conventional injections. TCM injections have higher risk of adverse effects than any other dosage forms of TCM medications and higher percentage of new or serious adverse effects than conventional injections. A lot of work need to be done to clarify the huge amount of potential unknown adverse effects related to TCM injections.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adverse drug reaction; pharmacoepidemiology; spontaneous reporting system; traditional Chinese herbal injection; traditional Chinese medicine

Mesh:

Substances:

Year:  2019        PMID: 31131950     DOI: 10.1002/pds.4805

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  16 in total

1.  The profiles of biopsy-proven renal tubulointerstitial lesions in patients with glomerular disease.

Authors:  Jin Dong; Yanqin Li; Shuling Yue; Xiaoting Liu; Long Wang; Mengqi Xiong; Guobao Wang; Sheng Nie; Xin Xu
Journal:  Ann Transl Med       Date:  2020-09

2.  5-HMF induces anaphylactoid reactions in vivo and in vitro.

Authors:  Encan Li; Ni Lin; Ruirui Hao; Xiaoyu Fan; Lin Lin; Guang Hu; Sheng Lin; Jiuming He; Qingfen Zhu; Hongtao Jin
Journal:  Toxicol Rep       Date:  2020-10-16

3.  Identification of high-risk patients for ADR induced by traditional Chinese medicine injection: a nested case-control study.

Authors:  Cheng Jiang; Jie Shen; Dan Shou; Nani Wang; Jing Jing; Guodi Zhang; Jing Gu; Yunlong Tian; Caihua Sun; Jiaqi He; Jiaqi Ma; Xiaojun Wang; Gonghua Li
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

Review 4.  The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence.

Authors:  Dan Zhang; Bing Zhang; Jin-Tao Lv; Ri-Na Sa; Xiao-Meng Zhang; Zhi-Jian Lin
Journal:  Pharmacol Res       Date:  2020-05-05       Impact factor: 7.658

5.  Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China.

Authors:  Linhui Yang; Xiaofang Shangguan; Rui Huang; Yuanxuan Cai; Bishwajit Ghose; Shangfeng Tang
Journal:  Sci Rep       Date:  2021-04-23       Impact factor: 4.379

Review 6.  Immunomodulatory drug discovery from herbal medicines: Insights from organ-specific activity and xenobiotic defenses.

Authors:  Jue Shi; Jui-Hsia Weng; Timothy J Mitchison
Journal:  Elife       Date:  2021-11-15       Impact factor: 8.140

7.  The severity of adverse drug reactions and their influencing factors based on the ADR monitoring center of Henan Province.

Authors:  Ziqi Yan; Zhanchun Feng; Zhiming Jiao; Chaoyi Chen; Ganyi Wang; Da Feng
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

Review 8.  Quality Evaluation of Randomized Controlled Trials of Rhodiola Species: A Systematic Review.

Authors:  Xiuzhu Li; Weijie Chen; Yingqi Xu; Zuanji Liang; Hao Hu; Shengpeng Wang; Yitao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-01       Impact factor: 2.629

9.  Chromatographic fingerprints analysis and determination of seven components in Danmu preparations by HPLC-DAD/QTOF-MS.

Authors:  Nanxin Li; Jinju Zhang; Ying Zhang; Zhiguo Ma; Jinhong Liao; Hui Cao; Menghua Wu
Journal:  Chin Med       Date:  2020-02-18       Impact factor: 5.455

10.  A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016.

Authors:  Hen-Hong Chang; Su-Yin Chiang; Pei-Chun Chen; Chia-Han Tsai; Rong-Chi Yang; Chiu-Lin Tsai; Tsung-Hsiu Wu; Yow-Wen Hsieh; Yu-Chun Lin; Yung-Te Kuo; Kuan-Chung Chen; Hsueh-Ting Chu
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.